SE330955B - - Google Patents
Info
- Publication number
- SE330955B SE330955B SE06470/65A SE647065A SE330955B SE 330955 B SE330955 B SE 330955B SE 06470/65 A SE06470/65 A SE 06470/65A SE 647065 A SE647065 A SE 647065A SE 330955 B SE330955 B SE 330955B
- Authority
- SE
- Sweden
- Prior art keywords
- weight
- therapeutically active
- acid
- solid
- amphiphilic agent
- Prior art date
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 4
- 239000002202 Polyethylene glycol Substances 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000002245 particle Substances 0.000 abstract 3
- 229920001223 polyethylene glycol Polymers 0.000 abstract 3
- 238000002360 preparation method Methods 0.000 abstract 3
- 239000007787 solid Substances 0.000 abstract 3
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 abstract 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- QBPFLULOKWLNNW-UHFFFAOYSA-N chrysazin Chemical compound O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O QBPFLULOKWLNNW-UHFFFAOYSA-N 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052742 iron Inorganic materials 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- WSPOMRSOLSGNFJ-AUWJEWJLSA-N (Z)-chlorprothixene Chemical compound C1=C(Cl)C=C2C(=C/CCN(C)C)\C3=CC=CC=C3SC2=C1 WSPOMRSOLSGNFJ-AUWJEWJLSA-N 0.000 abstract 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 1
- OTEKOJQFKOIXMU-UHFFFAOYSA-N 1,4-bis(trichloromethyl)benzene Chemical compound ClC(Cl)(Cl)C1=CC=C(C(Cl)(Cl)Cl)C=C1 OTEKOJQFKOIXMU-UHFFFAOYSA-N 0.000 abstract 1
- 241001116389 Aloe Species 0.000 abstract 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 abstract 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 abstract 1
- 235000001258 Cinchona calisaya Nutrition 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 240000003450 Mallotus philippensis Species 0.000 abstract 1
- 229930193140 Neomycin Natural products 0.000 abstract 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 235000011399 aloe vera Nutrition 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000007854 aminals Chemical class 0.000 abstract 1
- 229960000212 aminophenazone Drugs 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229910052785 arsenic Inorganic materials 0.000 abstract 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 abstract 1
- 229940125717 barbiturate Drugs 0.000 abstract 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 abstract 1
- 229960002327 chloral hydrate Drugs 0.000 abstract 1
- 229960005091 chloramphenicol Drugs 0.000 abstract 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 abstract 1
- 229960004782 chlordiazepoxide Drugs 0.000 abstract 1
- ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 abstract 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 abstract 1
- 229960001076 chlorpromazine Drugs 0.000 abstract 1
- 229960001552 chlorprothixene Drugs 0.000 abstract 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 abstract 1
- 229910017052 cobalt Inorganic materials 0.000 abstract 1
- 239000010941 cobalt Substances 0.000 abstract 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 abstract 1
- 229940117173 croton oil Drugs 0.000 abstract 1
- 229960001577 dantron Drugs 0.000 abstract 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 abstract 1
- 229960003529 diazepam Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000002191 fatty alcohols Chemical class 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 abstract 1
- 239000004312 hexamethylene tetramine Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000009355 kamala Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 150000002731 mercury compounds Chemical class 0.000 abstract 1
- 229960004011 methenamine Drugs 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 229960004927 neomycin Drugs 0.000 abstract 1
- 229940127240 opiate Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000419 plant extract Substances 0.000 abstract 1
- 229920000151 polyglycol Polymers 0.000 abstract 1
- 239000010695 polyglycol Substances 0.000 abstract 1
- 229960000948 quinine Drugs 0.000 abstract 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 abstract 1
- 229960001860 salicylate Drugs 0.000 abstract 1
- 239000000344 soap Substances 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH673264 | 1964-05-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE330955B true SE330955B (xx) | 1970-12-07 |
Family
ID=4314171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE06470/65A SE330955B (xx) | 1964-05-22 | 1965-05-18 |
Country Status (10)
Country | Link |
---|---|
US (1) | US3466362A (xx) |
BE (1) | BE664197A (xx) |
BR (1) | BR6569726D0 (xx) |
DE (1) | DE1467938C3 (xx) |
DK (1) | DK119079B (xx) |
FR (1) | FR1455118A (xx) |
GB (1) | GB1055854A (xx) |
IL (1) | IL23502A (xx) |
NL (1) | NL6505953A (xx) |
SE (1) | SE330955B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7314765A (xx) * | 1972-10-31 | 1974-05-02 | ||
DE2966564D1 (en) * | 1978-11-20 | 1984-02-23 | American Home Prod | Therapeutic compositions with enhanced bioavailability and process for their preparation |
US4344934A (en) * | 1978-11-20 | 1982-08-17 | American Home Products Corporation | Therapeutic compositions with enhanced bioavailability |
FR2552992A1 (fr) * | 1983-10-11 | 1985-04-12 | Havot Alain | Composition equilibree pour stopper la chute des cheveux et la calvitie precoce |
DE69102900T3 (de) * | 1990-02-14 | 1998-04-09 | Takeda Chemical Industries Ltd | Brausemischung, deren Herstellung sowie Verwendung. |
US6649186B1 (en) | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
US6488961B1 (en) | 1996-09-20 | 2002-12-03 | Ethypharm, Inc. | Effervescent granules and methods for their preparation |
US6169118B1 (en) | 1998-11-12 | 2001-01-02 | Block Drug Company, Inc. | Flavor blend for masking unpleasant taste of zinc compounds |
US7348027B2 (en) * | 2005-04-08 | 2008-03-25 | Bayer Healthcare Llc | Taste masked veterinary formulation |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
CN101801415B (zh) | 2007-05-25 | 2015-09-23 | Rb医药品有限公司 | 利培酮化合物的持续递送制剂 |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB906422A (en) * | 1958-05-02 | 1962-09-19 | Wellcome Found | Improvements in and relating to prolonged acting pharmaceutical preparations |
US3096248A (en) * | 1959-04-06 | 1963-07-02 | Rexall Drug & Chemical Company | Method of making an encapsulated tablet |
US3108046A (en) * | 1960-11-25 | 1963-10-22 | Smith Kline French Lab | Method of preparing high dosage sustained release tablet and product of this method |
US3139383A (en) * | 1961-06-26 | 1964-06-30 | Norton Co | Encapsulated time release pellets and method for encapsulating the same |
US3170836A (en) * | 1962-05-24 | 1965-02-23 | Glaxo Lab Ltd | Injectable compositions comprising a copper-containing chelate complex compound dispersed in a stabilized oil-in-water emulsion and method of using the same |
US3244595A (en) * | 1965-05-07 | 1966-04-05 | Mattox And Moore Inc | Composition for administering vitamins a, d, and e |
-
1965
- 1965-04-12 DE DE1467938A patent/DE1467938C3/de not_active Expired
- 1965-05-10 IL IL23502A patent/IL23502A/xx unknown
- 1965-05-11 NL NL6505953A patent/NL6505953A/xx unknown
- 1965-05-13 US US455582A patent/US3466362A/en not_active Expired - Lifetime
- 1965-05-18 FR FR17361A patent/FR1455118A/fr not_active Expired
- 1965-05-18 SE SE06470/65A patent/SE330955B/xx unknown
- 1965-05-19 BR BR169726/65A patent/BR6569726D0/pt unknown
- 1965-05-19 GB GB21228/65A patent/GB1055854A/en not_active Expired
- 1965-05-20 BE BE664197A patent/BE664197A/xx unknown
- 1965-05-21 DK DK258865AA patent/DK119079B/da unknown
Also Published As
Publication number | Publication date |
---|---|
FR1455118A (fr) | 1966-10-14 |
DK119079B (da) | 1970-11-09 |
IL23502A (en) | 1969-01-29 |
BE664197A (xx) | 1965-11-22 |
DE1467938A1 (de) | 1969-03-13 |
NL6505953A (xx) | 1965-11-23 |
BR6569726D0 (pt) | 1973-08-16 |
DE1467938C3 (de) | 1973-12-20 |
US3466362A (en) | 1969-09-09 |
GB1055854A (en) | 1967-01-18 |
DE1467938B2 (de) | 1973-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE330955B (xx) | ||
US2875130A (en) | Method of preparing sustained release particles and the product of the method | |
US3929985A (en) | Anhydrous candicidin foam compositions | |
US2854378A (en) | Tetracycline suppository | |
CA1114744A (en) | Pharmaceutical compositions containing urea | |
US4312889A (en) | Liquid carrier concentrate for pre-loaded cup | |
JPS62501908A (ja) | 薬理的組成物及びそれを含有する薬理的製剤 | |
US3154470A (en) | Stable depilatory compositions | |
US3085942A (en) | Antitussive compositions and preparation | |
GB1113860A (en) | Sustained release composition | |
SI9820010A (sl) | Trdne farmacevtske zmesi, vsebujoče ciklosporin in anionsko površinsko aktivno snov | |
JPH0249719A (ja) | 易水分散・可溶性能を有する油溶性ビタミン粉末 | |
US3037911A (en) | Chewable, palatable, vitamin b preparations | |
JPS6030650B2 (ja) | 座薬基剤組成物 | |
US3259545A (en) | Stable aluminum hydroxide gel or aluminum hydroxide-sodium zirconium lactate antiperspirant stick | |
GB2081092A (en) | Improving taste acceptability of pharmaceutical compositions | |
US3300387A (en) | Pressed powder antiperspirant and method of preparation | |
GB2033915A (en) | Organopolysiloxane/silica pharmaceutical compositions | |
US3577492A (en) | Tableting lubricant | |
JPH0461853B2 (xx) | ||
JPS5649314A (en) | Lasting pharmaceutical composition having prolonged action and its preparation | |
JPS61122213A (ja) | dl―6―フェニル―2,3,5,6―テトラヒドロイミダゾ〔2,1―b〕チアゾールのレジネートを含むペースト状駆虫組成物 | |
US3689678A (en) | Solid bath oil composition containing a clathrate | |
US3398225A (en) | Coated 2, 2-dichlorovinyl phosphate and polyvinyl chloride resin anthelmintic compositions | |
JPS5612306A (en) | Novel base for external preparation |